Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 238 clinical trials
ESCAP-2020-CPHG: Treatment Strategies Follow-up Implemented During the First Three Years Following Primary Lung Cancer (PLC) Diagnosed in KBP-2020-CPHG Cohort Patients

The prognosis for primary lung cancer (PLC) is very limited. In France, patients diagnosed for PLC in 2010 and followed in Respiratory Medicine or Oncology department of a General Hospital Centre had a 5-year survival rate of 12.7% (vs 10% in 2000).

lung cancer
cancer
immunohistochemistry
liquid biopsy
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.

The aim of the present prospective cohort study (GGN-F) is to study the family aggregation of pulmonary ground glass nodules via the questionnaire survey and to investigate the underlying genetic mechanism via the biobank.

lung cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.

lung cancer
cancer
covid-19
blood test
elisa
  • 0 views
  • 05 Aug, 2020
Pulmonary Embolism Prognosis Model

The purpose of this study is to analyze the clinical manifestations, imaging features, and prognosis-related factors of pulmonary embolism, and to explore the prognosis risk assessment model for Chinese patients

embolism
pulmonary embolism
  • 0 views
  • 16 Feb, 2024
  • 1 location
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) (GP)

The purposes of this study are: to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

  • 0 views
  • 01 Feb, 2024
  • 1 location
Clinical Study on Raman Spectra of Blood Saliva and Urine in Patients With Cancer Treated by Modern Therapy

Blood, saliva and urine samples of tumor patients on the day of admission and discharge were collected for Raman spectral analysis, which provided exploration for the prediction of efficacy, follow-up and prognosis according to the variation characteristics of Raman spectral.

cancer
targeted therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System

It is planned to integrate various services based on computer vision technologies for analysis of the certain type of x-ray study into Moscow Unified Radiological Information Service (hereinafter referred to as URIS). As a result of using computer vision-based services, it is expected: Reducing the number of false negative and …

ct scan
cancer
lung cancer
x-rays
breast cancer
  • 0 views
  • 05 Aug, 2020
Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.

pneumonia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

To determine the optimal EGFR TKIs treatment strategies for lung adenocarcinoma harboring EGFR exon 19 deletion variants

  • 0 views
  • 05 Aug, 2020
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

This study will evaluate the persistence of immunogenicity following a reduced dosing schedule of 10- or 13-valent Pneumococcal Conjugate Vaccine (PCV10, PCV13). This is the follow-up of a randomized controlled trial in which children received a single priming dose of PCV10 or PCV13 (at 6 or 14 weeks of age) …

pneumococcal
vaccination
booster
conjugate vaccine
pneumococcal conjugate
  • 0 views
  • 16 Feb, 2024
  • 1 location